This paper reviews the factors which make non-immune pregnant women particularly vulnerable to falciparum malaria and examines the problems of adequately protecting them in relation to current control strategies.
Women are most at risk in areas of high and continuous transmission, particularly during their first pregnancy, and also under conditions of unstable malaria which do not permit immunity to develop.
Chemoprophylaxis is recommended for pregnant women in holoendemic and hyperendemic areas in Africa and Papua New Guinea.
Chloroquine is safe, but drug resistance problems are beginning to limit its utility.
Distribution is a formidable problem in rural areas with a poorly developed health care infrastructure, and research studies reveal widespread ignorance and lack of motivation.
Mots-clés Pascal : Paludisme, Protozoose, Infection, Gestation, Chimiothérapie, Femme, Homme, Facteur risque, Sexe, Politique sanitaire, Traitement, Prévention, Article synthèse, Surveillance sanitaire, Pays en développement, Accessibilité, Soin, Système santé
Mots-clés Pascal anglais : Malaria, Protozoal disease, Infection, Pregnancy, Chemotherapy, Woman, Human, Risk factor, Sex, Health policy, Treatment, Prevention, Review, Sanitary surveillance, Developing countries, Accessibility, Care, Health system
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0555116
Code Inist : 002B05E02B4. Création : 199406.